These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 22538548)
1. Gantrez AN nanoparticles for ocular delivery of memantine: in vitro release evaluation in albino rabbits. Prieto E; Puente B; Uixera A; Garcia de Jalon JA; Perez S; Pablo L; Irache JM; Garcia MA; Bregante MA Ophthalmic Res; 2012; 48(3):109-17. PubMed ID: 22538548 [TBL] [Abstract][Full Text] [Related]
2. Vitreous pharmacokinetics and bioavailability of memantine after subtenon, intravenous, and intravitreal administration in rabbits. Prieto E; Pérez S; Pablo LE; García MA; Bregante MA J Ocul Pharmacol Ther; 2014 Jun; 30(5):392-9. PubMed ID: 24597794 [TBL] [Abstract][Full Text] [Related]
3. Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies. Aksungur P; Demirbilek M; Denkbaş EB; Vandervoort J; Ludwig A; Unlü N J Control Release; 2011 May; 151(3):286-94. PubMed ID: 21241752 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures. Hare WA; WoldeMussie E; Lai RK; Ton H; Ruiz G; Chun T; Wheeler L Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2625-39. PubMed ID: 15277486 [TBL] [Abstract][Full Text] [Related]
6. Influence of reaction medium during synthesis of Gantrez AN 119 nanoparticles for oral vaccination. Vandamme K; Melkebeek V; Cox E; Deforce D; Lenoir J; Adriaens E; Vervaet C; Remon JP Eur J Pharm Biopharm; 2010 Feb; 74(2):202-8. PubMed ID: 19819332 [TBL] [Abstract][Full Text] [Related]
7. Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: In vitro and pharmacokinetics studies. Bhatta RS; Chandasana H; Chhonker YS; Rathi C; Kumar D; Mitra K; Shukla PK Int J Pharm; 2012 Aug; 432(1-2):105-12. PubMed ID: 22569234 [TBL] [Abstract][Full Text] [Related]
8. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density. Essa S; Rabanel JM; Hildgen P Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis. Cheng CK; Berger AS; Pearson PA; Ashton P; Jaffe GJ Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):442-53. PubMed ID: 7843913 [TBL] [Abstract][Full Text] [Related]
10. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide. Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412 [TBL] [Abstract][Full Text] [Related]
16. Ionic complexation as a non-covalent approach for the design of folate anchored rifampicin Gantrez nanoparticles. Date PV; Patel MD; Majee SB; Samad A; Devarajan PV J Biomed Nanotechnol; 2013 May; 9(5):765-75. PubMed ID: 23802406 [TBL] [Abstract][Full Text] [Related]
17. Effect of intravitreal injection of norfloxacin on the retina in pigmented rabbits. Tanahashi T; Mochizuki K; Torisaki M; Yamashita Y; Komatsu M; Higashide T; Ogata M Lens Eye Toxic Res; 1992; 9(3-4):493-503. PubMed ID: 1301799 [TBL] [Abstract][Full Text] [Related]
18. An HPLC with evaporative light scattering detection method for the quantification of PEGs and Gantrez in PEGylated nanoparticles. Zabaleta V; Campanero MA; Irache JM J Pharm Biomed Anal; 2007 Sep; 44(5):1072-8. PubMed ID: 17587532 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal recombinant human erythropoietin: a safety study in rabbits. Song BJ; Cai H; Tsai JC; Chang S; Forbes M; Del Priore LV Curr Eye Res; 2008 Sep; 33(9):750-60. PubMed ID: 18798078 [TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation. Wadhwa S; Paliwal R; Paliwal SR; Vyas SP J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]